Isobel Reid
About Isobel Reid
Isobel Reid is the Executive Director of Patient Safety Intercon at Bristol Myers Squibb in Melbourne, Victoria, Australia, with extensive experience in medical information and pharmacovigilance.
Title
Isobel Reid holds the position of Executive Director Patient Safety Intercon. She is currently employed with Bristol Myers Squibb in Melbourne, Victoria, Australia.
Professional Experience at Bristol Myers Squibb
Isobel Reid has an extensive career at Bristol Myers Squibb, spanning multiple positions. She started as a Senior/Medical Information Pharmacist in the UK from 1999 to 2001, followed by roles as Senior Medical Services Manager in Australia (2001-2003), Associate Director, Medical Information, Asia Pacific (2004-2008), and Regional Director, Pharmacovigilance & Medical Information (2008-2012). From 2012 to 2020, she served as Regional Director, Pharmacovigilance, and currently serves as the Executive Director Patient Safety Intercon in Melbourne, Australia.
Experience at Therapeutic Goods Administration
Prior to her tenure at Bristol Myers Squibb, Isobel Reid worked at the Therapeutic Goods Administration. She held roles as Clinical Evaluation Unit Pharmacist and Ministerial & Project Office Pharmacist, where she was involved with the Experimental Drugs Group from 1995 to 1998.
Early Career at Woden Valley Hospital
Isobel Reid began her professional career as a Clinical Pharmacist at Woden Valley Hospital. She held this role from 1989 to 1995, marking six years of foundational experience in clinical pharmacy.
Educational Background
Isobel Reid earned her Bachelor of Pharmacy (B.Pharm.) from the University of Tasmania. She completed her studies between 1987 and 1989, providing a solid academic foundation for her subsequent professional roles.